Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
about
Huntingtin is critical both pre- and postsynaptically for long-term learning-related synaptic plasticity in AplysiaThe risk of re-identification versus the need to identify individuals in rare disease researchRating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data.Existing data sources for clinical epidemiology: Danish registries for studies of medical genetic diseases.Neuropsychiatric Burden in Huntington's Disease.A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset.The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.Default-mode network changes in Huntington's disease: an integrated MRI study of functional connectivity and morphometry.A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.The role of tau in the pathological process and clinical expression of Huntington's diseaseNovel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease PatientsImplementation and Outcomes of a Collaborative Multi-Center Network Aimed at Web-Based Cognitive Training - COGWEB Network.Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease.Intact sensory-motor network structure and function in far from onset premanifest Huntington's diseasePathways to decoding the clinical potential of stress response FOXO-interaction networks for Huntington's disease: of gene prioritization and context dependence.Genetic modifiers of Huntington's disease.Body weight is a robust predictor of clinical progression in Huntington disease.Validation of a prognostic index for Huntington's disease.Identification of extreme motor phenotypes in Huntington's disease.Towards a European Registry and Biorepository for Patients with Spinal and Bulbar Muscular Atrophy.Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease.Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach.[Predictors of mental and physical quality of life in Huntington's disease].Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders.Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.Overlap between age-at-onset and disease-progression determinants in Huntington disease.Perinatal insults and neurodevelopmental disorders may impact Huntington's disease age of diagnosis
P2860
Q21131986-7310833D-95B6-42D7-8D2B-9A1CB76247E3Q28595728-37B2AAF6-6E5E-4676-BEAA-6EDF6978A2C8Q30249645-46D5ED42-9884-44A5-B00D-31407E2F490FQ30622209-60880764-65B6-4F0F-AFDA-8F86C4BFC4BCQ30662801-09A3368E-E02C-49C3-9D7B-EFD1CA0D9956Q33831793-9B11A95A-C1EF-45EF-8775-0ED28300E37FQ34275231-0287EAD6-6D8C-46FB-9CF4-631F020DBEB3Q34873673-1645C796-64D0-4F41-8756-930D75DD468EQ34973519-3F3EBA29-BDA7-4CE0-BE88-4E23BABFB369Q35079574-D54FF243-2905-4CBE-AB66-D276F7721DA2Q36066666-1C18359F-E1A2-462C-A8EB-36A3C1848CE2Q36127832-73E96847-9267-4D46-8C56-56A8C394E111Q36166457-7AD45775-C421-4E9A-A2BB-A92E6FA25256Q36336471-28EF5E99-87DF-47E6-8757-96F0ACEC19FDQ37603963-47A30BAA-A55E-4977-B19E-79CB456E09DFQ37683775-96FA7097-3B38-4CEE-BA18-F03A673CF59EQ38115523-E8703C59-5C84-42AA-B22B-C65F629F1AC4Q38243002-DE4FA066-F35A-498C-BF73-E8256AA9CC14Q38639328-500879E3-365E-4875-B853-F8E5E54165FAQ38790095-6B830601-C1C0-431C-BB32-D63C63BFEC6EQ39169547-EAA4459A-6742-4DBD-9327-74C2E6E2A0F8Q40991752-35D685B4-BF5A-49B3-8C88-7FA532CB6A15Q45290173-EC4BBCE7-BFD5-41D0-A240-AC1E232E6E59Q45294016-49987108-82A1-44D2-8EB0-0D4C9C7C4FEBQ45304110-2E9E1EA0-16BA-4629-8004-490969499AA2Q49608512-A60052F6-EC19-4188-9CDB-686576EFB91FQ52685691-195D2208-A449-4E77-9995-2B5675144DEBQ55196259-D3350259-4264-40CA-98EB-824ADE06EC05Q59132032-EC9B1263-DA19-4065-AB02-F70290D8D62C
P2860
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@en
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@nl
type
label
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@en
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@nl
prefLabel
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@en
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@nl
P2093
P356
P1476
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.
@en
P2093
C Schwenke
European Huntington's Disease Network
G B Landwehrmeyer
O J Handley
S J Tabrizi
P304
P356
10.1136/JNNP.2010.209668
P407
P50
P577
2010-11-19T00:00:00Z